New hope for kids with tough brain cancers: trial tests Immune-Boosting drug
Disease control
Ongoing
This study is testing whether adding an immunotherapy drug called indoximod to standard chemotherapy and radiation can better control aggressive brain tumors in children and young adults. It is for patients aged 3 to 21 with certain progressive brain cancers or a newly diagnosed,…
Phase: PHASE2 • Sponsor: Theodore S. Johnson • Aim: Disease control
Last updated Mar 10, 2026 12:53 UTC